Premium
Adaptive Biomedical Innovation
Author(s) -
Honig PK,
Hirsch G
Publication year - 2016
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.513
Subject(s) - product innovation , business , innovation process , product (mathematics) , knowledge management , process (computing) , process management , fragmentation (computing) , computer science , marketing , work in process , geometry , mathematics , operating system
Adaptive Biomedical Innovation (ABI) is a multistakeholder approach to product and process innovation aimed at accelerating the delivery of clinical value to patients and society. ABI offers the opportunity to transcend the fragmentation and linearity of decision‐making in our current model and create a common collaborative framework that optimizes the benefit and access of new medicines for patients as well as creating a more sustainable innovation ecosystem.